PEPTIDES . OLIGONUCLEOTIDES . STERILE FORMULATIONS

Raysun Biopharma Integrated CDMO from API to Sterile Fill-Finish

Raysun Biopharma is developing an integrated CDMO platform focused on peptides and oligonucleotides, connecting API capabilities with formulation development, analytical support, sterile fill-finish and finished dosage form manufacturing.

Based in Vientiane, Lao PDR, our manufacturing facility is designed and being developed to EU GMP standards, with planned capabilities for lyophilized vials, single- and dual-chamber cartridges, and other sterile injectable formulations for qualified international programs.

WATCH FULL VIDEO

A Focused Platform for Complex APIs and Sterile Drug Products

Raysun's integrated service model is being developed around four connected areas. Each program is assessed for technical, quality and regulatory fit before scope is defined.

Peptide API & Sterile FDF

Development pathways for peptide drug substance and sterile cartridge or lyophilized-vial presentations.

Growth Hormone API & FDF

A planned program scope covering growth hormone active ingredient and corresponding finished dosage-form development.

Sterile Oligonucleotide Formulation

Planned formulation and sterile drug-product support for suitable oligonucleotide programs.

FDF Development & CDMO

Formulation, process development, analytical planning, technology transfer, scale-up and future GMP manufacturing support.

VIENTIANE, LAO PDR

Raysun Biopharma

Raysun Biopharma (Raysunpep) is based in Nakha village, Naxaithong district, Vientiane capital city, Laos. We work exclusively with pharmaceutical companies, biotechnology companies and R&D institutions through a project-review process.

LEARN MORE